Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces that it will be present at the following investor events:
- H.C. Wainwright Global Life Sciences Conference – Monaco, April 9-10, 2018
- Goldman Sachs 11th European Small and Mid-Cap Symposium – London, May 1‑4, 2018
- Deutsche Bank’s 43rd Healthcare Conference – Boston, USA, May 8-9, 2018
Innate Pharma is committed to meet on a regular basis with the financial community. All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (www.innate-pharma.com/en/investors).